Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension | Journal of Pharmacology and Experimental
Aging and endothelin: Determinants of disease - ScienceDirect
The Endothelin System and Its Antagonism in Chronic Kidney Disease | American Society of Nephrology
The Endothelin System and Its Antagonism in Chronic Kidney Disease | American Society of Nephrology
Pathophysiological Role of Endothelin and Potential Therapeutic Targets for Receptor Antagonists | SpringerLink
Big ET1 ELISA kit (Human Big Endothelin-1) | BI-20082H | Biomedica
Biology | Free Full-Text | Endothelin and the Cardiovascular System: The Long Journey and Where We Are Going | HTML
MicroRNAs and obesity-induced endothelial dysfunction: key paradigms in molecular therapy | Cardiovascular Diabetology | Full Text
Venous endothelin guides sympathetic innervation of the developing mouse heart | Nature Communications
Endothelins in health and disease - European Journal of Internal Medicine
Endothelins and Endothelin Receptor Antagonists | Circulation
Endothelin: 30 Years From Discovery to Therapy | Hypertension
Circulating Endothelin-1 Alters Critical Mechanisms Regulating Cerebral Microcirculation | Hypertension
Endothelin and the Cardiovascular System: The Long Journey and Where We Are Going
Endothelin-1 (ET-1) concentration–response curves in basilar artery. a... | Download Scientific Diagram
Endothelins and Endothelin Receptor Antagonists | Circulation
JCDD | Free Full-Text | Mechanisms and Clinical Implications of Endothelial Dysfunction in Arterial Hypertension | HTML
Biology | Free Full-Text | Endothelin and the Cardiovascular System: The Long Journey and Where We Are Going | HTML
Aging and endothelin: Determinants of disease - ScienceDirect
Endothelin: Potential Role in Hypertension and Vascular Hypertrophy | Hypertension
Endothelin Receptors | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Frontiers | SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress
Endothelins and Endothelin Receptor Antagonists | Circulation
